Hypersensitivity Reactions to Anticancer Nanodrugs and Biologicals

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户:yhz8668
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Hypersensitivity reactions (HSRs) are frequent side effects of iv.administered anticancer nanomedicines and biologicals.These,occasionally severe or fatal allergic reactions are due,at least in part,to activation of the complement (C) system,hence they are called C activation-related pseudoallergy (CARPA).
其他文献
Approximately 70% of the South African population consults traditional healers,perpetuating the need for scientific appraisal of traditional medicine as a means to establish its efficiency and safety
会议
Hepatocellular carcinoma (HCC) is the most common type of liver cancer,the second most common cause of death from cancer worldwide.A very poor prognosis and a lack of effective treatments make HCC a m
会议
Toxicities associated with chemotherapies often limit their effectiveness,and warrant development of new and safe anti-cancer agents.
会议
The natural compound n-butylidenephthalide (BP) can pass through the blood-brain barrier to inhibit the growth of glioblastoma multiforme tumors.
会议
The aqueous ethanol extract of Thalassia testudinum (TTE) leaves is under study in Cuba as nutritional supplement due to its promising pharmacological properties.
会议
Cancer is a multigenic disease associated to chronic inflammation,which in turn is associated to oxidative stress.The main problems of the anti-cancer chemotherapy are their lack of specificity and th
会议
Patient-derived xenograft (PDX) models have been used increasingly to evaluate new anti-cancer therapies to support clinical trials.These PDX models are better preserving the original tumor heterogene
会议
Since the human genome had been sequenced,the advance of biotechnologies has led to a substantial decrease of the procedure cost from 100 million dollars to 1,000 dollars per individuals genome.Such p
会议
Background: Head and neck squamous cell carcinoma (HNSCC) patients who progress after first-line platinum-based chemotherapy (CT) for recurrent and/or metastatic (R/M) disease have few treatment optio
会议
Background: Following curatively intended chemo-radiotherapy (CRT),standard of care for locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) is observation,and recurrence is comm
会议